Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.9M
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
3.18M
-
Shares change
-
+226K
-
Total reported value, excl. options
-
$15.2M
-
Value change
-
+$1.1M
-
Put/Call ratio
-
1.44
-
Number of buys
-
15
-
Number of sells
-
-13
-
Price
-
$4.77
Significant Holders of Anixa Biosciences Inc - Common Stock (ANIX) as of Q3 2021
42 filings reported holding ANIX - Anixa Biosciences Inc - Common Stock as of Q3 2021.
Anixa Biosciences Inc - Common Stock (ANIX) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.18M shares
of 37.9M outstanding shares and own 8.39% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.3M shares), UBS Group AG (582K shares), GEODE CAPITAL MANAGEMENT, LLC (264K shares), RENAISSANCE TECHNOLOGIES LLC (212K shares), BlackRock Inc. (110K shares), Bank of New York Mellon Corp (98.7K shares), STATE STREET CORP (90.9K shares), NORTHERN TRUST CORP (61.3K shares), TWO SIGMA ADVISERS, LP (56.5K shares), and TWO SIGMA INVESTMENTS, LP (52.1K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.